MAIA Biotechnology Statistics
Total Valuation
MAIA has a market cap or net worth of $92.10 million. The enterprise value is $81.20 million.
Important Dates
The next estimated earnings date is Friday, March 20, 2026, after market close.
| Earnings Date | Mar 20, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
MAIA has 58.66 million shares outstanding. The number of shares has increased by 46.79% in one year.
| Current Share Class | 58.66M |
| Shares Outstanding | 58.66M |
| Shares Change (YoY) | +46.79% |
| Shares Change (QoQ) | +9.58% |
| Owned by Insiders (%) | 8.56% |
| Owned by Institutions (%) | 4.30% |
| Float | 53.61M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 2,210.12 |
| P/TBV Ratio | 2,210.12 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.18
| Current Ratio | 1.18 |
| Quick Ratio | 1.10 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -2,691.07% and return on invested capital (ROIC) is -1,879.00%.
| Return on Equity (ROE) | -2,691.07% |
| Return on Assets (ROA) | -148.38% |
| Return on Invested Capital (ROIC) | -1,879.00% |
| Return on Capital Employed (ROCE) | -1,396.14% |
| Weighted Average Cost of Capital (WACC) | 4.13% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.72M |
| Employee Count | 13 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -0.63% in the last 52 weeks. The beta is -0.02, so MAIA's price volatility has been lower than the market average.
| Beta (5Y) | -0.02 |
| 52-Week Price Change | -0.63% |
| 50-Day Moving Average | 1.93 |
| 200-Day Moving Average | 1.62 |
| Relative Strength Index (RSI) | 40.17 |
| Average Volume (20 Days) | 1,252,958 |
Short Selling Information
The latest short interest is 2.09 million, so 3.56% of the outstanding shares have been sold short.
| Short Interest | 2.09M |
| Short Previous Month | 1.63M |
| Short % of Shares Out | 3.56% |
| Short % of Float | 3.89% |
| Short Ratio (days to cover) | 1.71 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -24.96M |
| Pretax Income | -22.34M |
| Net Income | -22.34M |
| EBITDA | n/a |
| EBIT | -24.96M |
| Earnings Per Share (EPS) | -$0.77 |
Full Income StatementBalance Sheet
The company has $10.89 million in cash and n/a in debt, with a net cash position of $10.89 million or $0.19 per share.
| Cash & Cash Equivalents | 10.89M |
| Total Debt | n/a |
| Net Cash | 10.89M |
| Net Cash Per Share | $0.19 |
| Equity (Book Value) | 41,670 |
| Book Value Per Share | 0.00 |
| Working Capital | 1.76M |
Full Balance SheetCash Flow
| Operating Cash Flow | -15.73M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
